166 related articles for article (PubMed ID: 38110666)
21. TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms.
Fang WB; Mafuvadze B; Yao M; Zou A; Portsche M; Cheng N
PLoS One; 2015; 10(8):e0135063. PubMed ID: 26252654
[TBL] [Abstract][Full Text] [Related]
22. Desuppression of TGF-β signaling via nuclear c-Abl-mediated phosphorylation of TIF1γ/TRIM33 at Tyr-524, -610, and -1048.
Yuki R; Tatewaki T; Yamaguchi N; Aoyama K; Honda T; Kubota S; Morii M; Manabe I; Kuga T; Tomonaga T; Yamaguchi N
Oncogene; 2019 Jan; 38(5):637-655. PubMed ID: 30177833
[TBL] [Abstract][Full Text] [Related]
23. Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis.
Wu MZ; Yuan YC; Huang BY; Chen JX; Li BK; Fang JH; Zhuang SM
Signal Transduct Target Ther; 2021 Nov; 6(1):395. PubMed ID: 34785655
[TBL] [Abstract][Full Text] [Related]
24. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway.
Yang HJ; Liu GL; Liu B; Liu T
J Cell Mol Med; 2018 Mar; 22(3):1650-1665. PubMed ID: 29349903
[TBL] [Abstract][Full Text] [Related]
25. p300 Acetyltransferase Is a Cytoplasm-to-Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β-Stimulated Hepatic Stellate Cells.
Wang Y; Tu K; Liu D; Guo L; Chen Y; Li Q; Maiers JL; Liu Z; Shah VH; Dou C; Tschumperlin D; Voneschen L; Yang R; Kang N
Hepatology; 2019 Oct; 70(4):1409-1423. PubMed ID: 31004519
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
Wicks SJ; Lui S; Abdel-Wahab N; Mason RM; Chantry A
Mol Cell Biol; 2000 Nov; 20(21):8103-11. PubMed ID: 11027280
[TBL] [Abstract][Full Text] [Related]
27. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E
Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor β-mediated site-specific Smad linker region phosphorylation in vascular endothelial cells.
Kamato D; Rostam MA; Piva TJ; Babaahmadi Rezaei H; Getachew R; Thach L; Bernard R; Zheng W; Little PJ; Osman N
J Pharm Pharmacol; 2014 Dec; 66(12):1722-33. PubMed ID: 25316549
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling.
Souchelnytskyi S; Tamaki K; Engström U; Wernstedt C; ten Dijke P; Heldin CH
J Biol Chem; 1997 Oct; 272(44):28107-15. PubMed ID: 9346966
[TBL] [Abstract][Full Text] [Related]
30. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
[TBL] [Abstract][Full Text] [Related]
32. Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle.
Rezaei HB; Kamato D; Ansari G; Osman N; Little PJ
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):661-7. PubMed ID: 21883378
[TBL] [Abstract][Full Text] [Related]
33. Transforming properties of MET receptor exon 14 skipping can be recapitulated by loss of the CBL ubiquitin ligase binding site.
Fernandes M; Paget S; Kherrouche Z; Truong MJ; Vinchent A; Meneboo JP; Sebda S; Werkmeister E; Descarpentries C; Figeac M; Cortot AB; Tulasne D
FEBS Lett; 2023 Sep; 597(18):2301-2315. PubMed ID: 37468447
[TBL] [Abstract][Full Text] [Related]
34. PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis.
Yeh HW; Hsu EC; Lee SS; Lang YD; Lin YC; Chang CY; Lee SY; Gu DL; Shih JH; Ho CM; Chen CF; Chen CT; Tu PH; Cheng CF; Chen RH; Yang RB; Jou YS
Nat Cell Biol; 2018 Apr; 20(4):479-491. PubMed ID: 29593326
[TBL] [Abstract][Full Text] [Related]
35. MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice.
Fernandes M; Hoggard B; Jamme P; Paget S; Truong MJ; Grégoire V; Vinchent A; Descarpentries C; Morabito A; Stanislovas J; Farage E; Meneboo JP; Sebda S; Bouchekioua-Bouzaghou K; Nollet M; Humez S; Perera T; Fromme P; Grumolato L; Figeac M; Copin MC; Tulasne D; Cortot AB; Kermorgant S; Kherrouche Z
Mol Oncol; 2023 Nov; 17(11):2257-2274. PubMed ID: 36799689
[TBL] [Abstract][Full Text] [Related]
36. The TGF-β/Smad
Yu ZL; Liu J; Ning ZK; Tian HK; Wu X; Huang YF; Wu ZC; Zong Z; Zhou TC
Mol Carcinog; 2023 Feb; 62(2):261-276. PubMed ID: 36345938
[TBL] [Abstract][Full Text] [Related]
37. Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping.
Heist RS; Sequist LV; Borger D; Gainor JF; Arellano RS; Le LP; Dias-Santagata D; Clark JW; Engelman JA; Shaw AT; Iafrate AJ
J Thorac Oncol; 2016 Aug; 11(8):1242-1245. PubMed ID: 27343442
[TBL] [Abstract][Full Text] [Related]
38. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
[TBL] [Abstract][Full Text] [Related]
39. Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 Skipping.
Ou SI; Young L; Schrock AB; Johnson A; Klempner SJ; Zhu VW; Miller VA; Ali SM
J Thorac Oncol; 2017 Jan; 12(1):137-140. PubMed ID: 27666659
[TBL] [Abstract][Full Text] [Related]
40. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.
Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S
J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
